论文部分内容阅读
阿里佳尼亚提醒:正常人服药的危险性远远高于其带来的益处为了能够给阿尔茨海默氏病(Alzheimer’s)和精神分裂症的患者提供更好更安全的药品,生物技术公司和大药厂已经着手开展以多重识别机制为靶点的药物开发项目。目前,一些药物已经进入到了临床研究的最后阶段。对于那些饱受这类疾病折磨的患者,长远来说,这些新药会使他们有了提高认知功能的希望,而目前的治疗方法,疗
Alicia Reminder: The dangers of taking medications far outweigh the benefits for normal people In order to provide better and more secure medicines for patients with Alzheimer’s and schizophrenia, biotech companies And the pharmaceutical giant has started to carry out multi-recognition mechanism for drug development projects. At present, some drugs have entered the final phase of clinical research. For those patients afflicted by such diseases, in the long run, these new drugs will give them the hope of improving their cognitive function. However, the current treatments and therapies